|
|
DSpace at RU >
Search Results
Results 1-27 of 27.
Item hits:
| Full Text | Issue Date | Title | Author(s) |  | 2012 | De behandeling van atriumfibrilleren | Jaspers Focks, J.; Pop, G.A.M.; Brouwer, M.A. |
| | 2012 | Clinical Trial Update On Optimal Antithrombotic Therapy In Non-Valvular AF. | Bonnes, J.L.; Brouwer, M.A. |
| | 2011 | Design of the Circulation Improving Resuscitation Care (CIRC) Trial: a new state of the art design for out-of-hospital cardiac arrest research | Lerner, E.B.; Persse, D.; Souders, C.M.; Sterz, F.; Malzer, R.; Lozano, M., Jr.; Westfall, M.; Brouwer, M.A.; Grunsven, P.M. van; Whitehead, A.; Olsen, J.A.; Herken, U.R.; Wik, L. |
| | 2010 | An error in the CoaguChek S device results in prosthetic heart valve thrombosis. | Brule, J.M. van den; Romkes, J.H.; Brouwer, M.A.; Noyez, L. |
| | 2010 | Pre-hospital triage for primary angioplasty: direct referral to the intervention center versus interhospital transport. | Dieker, H.J.; Liem, S.S.; Aidi, H. El; Grunsven, P. van; Aengevaeren, W.R.M.; Brouwer, M.A.; Verheugt, F.W.A. |
| | 2009 | The smoker's paradox after successful fibrinolysis: reduced risk of reocclusion but no improved long-term cardiac outcome. | Kievit, P.C.; Brouwer, M.A.; Veen, G.; Aengevaeren, W.R.M.; Verheugt, F.W.A. |
| | 2009 | Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis : from early reduction in reocclusion to improved long-term clinical outcome | Bergh, P.J.P.C. van den; Kievit, P.C.; Brouwer, M.A.; Aengevaeren, W.R.M.; Veen, G.; Verheugt, F.W.A. |
| | 2008 | How to react to high platelet reactivity? | Clappers, N.; Brouwer, M.A.; Verheugt, F.W.A. |
| | 2008 | Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial. | Brouwer, M.A.; Kievit, P.C.; Dieker, H.J.; Veen, G.; Karreman, A.J.; Verheugt, F.W.A. |
| | 2008 | The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid. | Clappers, N.; Oijen, M.G.H. van; Sundaresan, S.; Brouwer, M.A.; Morsche, R.H.M. te; Keuper, W.; Peters, W.H.M.; Drenth, J.P.H.; Verheugt, F.W.A. |
| | 2007 | Antiplatelet treatment for coronary heart disease. | Clappers, N.; Brouwer, M.A.; Verheugt, F.W.A. |
| | 2007 | Estrogen therapy and coronary-artery calcification. | Brouwer, M.A.; Dieker, H.J.; Verheugt, F.W.A. |
| | 2007 | Reperfusion therapy in out-of-hospital cardiac arrest: current insights. | Keuper, W.; Dieker, H.J.; Brouwer, M.A.; Verheugt, F.W.A. |
| | 2007 | Lack of concordance between a rapid bedside and conventional laboratory method of cardiac troponin testing: impact on risk stratification of patients suspected of acute coronary syndrome. | Cramer, G.E.; Kievit, P.C.; Brouwer, M.A.; Keijzer, M.H. de; Luijten, H.E.; Verheugt, F.W.A. |
| | 2007 | Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction. | Dieker, H.J.; French, J.K.; Joziasse, I.C.; Brouwer, M.A.; Elliott, J.; West, T.M.; Webber, B.J.; Verheugt, F.W.A.; White, H.D. |
| | 2006 | Prognostic implications of the blood pressure response to the Valsalva manoeuvre in elderly cardiac patients. | Remmen, J.J.; Jansen, R.W.M.M.; Aengevaeren, W.R.M.; Brouwer, M.A.; Verheugt, F.W.A. |
| | 2006 | Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS). | Dieker, H.J.; Horssen, E.V. van; Hersbach, F.M.; Brouwer, M.A.; Boven, A.J. van; Hof, A.W. van 't; Aengevaeren, W.R.M.; Verheugt, F.W.A.; Bar, F.W. |
| | 2005 | ESC guidelines for percutaneous coronary interventions. | Dieker, H.J.; Brouwer, M.A.; Verheugt, F.W.A. |
 | 2004 | Antithrombotic strategies and the impact of coronary reocclusion in ST-elevation myocardial infarction | Brouwer, M.A. |
| | 2004 | Adjunctive treatment in patients treated with thrombolytic therapy. | Brouwer, M.A.; Clappers, N.; Verheugt, F.W.A. |
| | 2004 | High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction. | Kievit, P.C.; Brouwer, M.A.; Veen, G.; Karreman, A.J.; Verheugt, F.W.A. |
| | 1997 | De waarde van een tuberculine-test na BCG-vaccinatie | Tolboom, J.J.M.; Brouwer, M.A. |
| | 1997 | Identification of patients at high risk after successful thrombolysis | Brouwer, M.A.; Meijer, A.; Eenige, M.J. van; Veen, G.; Pol, J.M.J. van der; Verheugt, F.W.A. |
| | 1996 | Long term outcome after early prehospital thrombolysis: influence on mortality and event free survival | Brouwer, M.A.; Maynard, C.; Martin, J.S.; Wirkus, M.; Verheugt, F.W.A.; Weaver, D.W. |
| | 1996 | Long term outcome after early prehospital thrombolysis: influence on mortality and event free survival | Brouwer, M.A.; Maynard, C.; Martin, J.S.; Wirkus, M.; Litwin, P.E.; Verheugt, F.W.A.; Weaver, D.W. |
| | 1996 | Influence of early prehospital thrombolysis on mortality and event-free survival (The myocardial infarction triage and intervention [MITI]randomized trial) | Brouwer, M.A.; Martin, J.S.; Maynard, C.; Wirkus, M.; Litwin, P.E.; Verheugt, F.W.A.; Weaver, D.W. |
| | 1995 | Adverse long-term effects of reocclusion after coronary thrombolysis | Brouwer, M.A.; Böhncke, J.R.; Veen, G.; Meijer, A.; Eenige, M.J. van; Verheugt, F.W.A. |
1
|
